Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis

ClinicalTrials.gov ID: NCT00106496

Public ClinicalTrials.gov record NCT00106496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 7:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Study to Assess the Impact of Topical Corticosteroids on the Safety and Efficacy of Protopic Ointment in the Short-Term Treatment of Atopic Dermatitis and to Assess Protopic in the Long-term Management of Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term management of Atopic Dermatitis

Study identification

NCT ID
NCT00106496
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
410 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Jun 30, 2006
Completion
Jun 30, 2006
Last update posted
Sep 17, 2014

2004 – 2006

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
21
Facility City State ZIP Site status
Investigational Site Birmingham Alabama 35205
Investigational Site Irvine California 92697
Investigational Site Loma Linda California 92354
Investigational Site San Diego California 92123
Not listed New Haven Connecticut 06519
Not listed Miami Florida 33136
Investigational Site Atlanta Georgia 30322
Investigational Site Chicago Illinois 60611
Not listed Chicago Illinois 60612
Investigational Site Chicago Illinois 60614
Not listed Lexington Kentucky 40536
Not listed Baltimore Maryland 21205
Investigational Site Ann Arbor Michigan 48109
Investigational Site Detroit Michigan 48202
Investigational Site St Louis Missouri 63110
Investigational Site Lebanon New Hampshire 03756
Investigational Site New York New York 10029
Investigational Site Winston-Salem North Carolina 27157
Investigational Site Cincinnati Ohio 45219
Investigational Site Portland Oregon 97201
Investigational Site Philadelphia Pennsylvania 19115
Investigational Site Nashville Tennessee 37215
Investigational Site Dallas Texas 75230
Investigational Site Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2014 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00106496 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →